Form D · Private Equity Fund

BioPharma Credit Investments V LP

George Town, Grand Cayman, E9 · CIK 0001771639

Offering snapshot reported May 28, 2026 · SEC filing

Reported sold
$1.59B
Indefinite offering
Investors reported
159
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jun 27, 2019
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$795M$1.59BJun 14, 2019May 29, 2020: $288,850,000.00May 28, 2021: $482,550,000.00Jun 3, 2022: $907,683,600.00Jun 2, 2023: $1,082,133,600.00May 30, 2024: $1,382,783,600.00May 28, 2025: $1,382,783,600.00May 28, 2026: $1,589,933,600.00May 28, 2026

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$1,382,783,600 → $1,589,933,600
  • Reported investors147 → 159

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
May 28, 2026Amendment$1,589,933,600$207,150,000vs May 28, 2025159SEC filing
May 28, 2025Amendment$1,382,783,600$0vs May 30, 2024147SEC filing
May 30, 2024Amendment$1,382,783,600$300,650,000vs Jun 2, 2023144SEC filing
Jun 2, 2023Amendment$1,082,133,600$174,450,000vs Jun 3, 2022124SEC filing
Jun 3, 2022Amendment$907,683,600$425,133,600vs May 28, 202188SEC filing
May 28, 2021Amendment$482,550,000$193,700,000vs May 29, 202054SEC filing
May 29, 2020Amendment$288,850,000No comparison31SEC filing
Jun 14, 2019InitialYet to sellNo comparison0SEC filing

Offering details

Securities
Equity, Pooled investment fund
Exemptions
06b, 3C, 3C.7
Duration over one year
Yes
Business combination
No
Sales commissions
$50K
Finders' fees
$0
Form D file number
021-342013
Groton Securities LLC is no longer in business. A new vehicle, 2M Management LLC, was created to accept payments in connection with one new investor payment. No ongoing relationship.

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
Groton Securities LLC126600

Source: Form D, filed May 28, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

The linked fund shows its most recently reported ADV details.

Matched by reported Form D file number

BIOPHARMA CREDIT INVESTMENTS V LP

Investment adviser: PHARMAKON ADVISORS, LP

Gross asset value
Not reported
Beneficial owners
Not reported
ADV minimum commitment
Not reported

Reported in Form ADV on Mar 31, 2026. Fund assets and beneficial owners measure different things from Form D sales and investors.

Service providers

No provider names available in this fund's imported disclosure.

Provider details
Annual audit
Not reported
Prime brokers
Not reported
Custodians
Not reported
Administrator other than the adviser
Not reported
External marketing
Not reported
Filing source

Form ADV 2085189 · Mar 31, 2026 · Schedule D 7.B.(1), fund 805-2393552382

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
N/A Bio Pharma Credit Investments V Gp Llc Director

Issuer details

Industry: Pooled Investment Fund (See others in industry)

Address:
Co Biopharma Credit Investments V Gp Llc 190 Elgin Avenue
George Town, Grand Cayman, E9, KY1-9008